Professor Waljit Dhillo
Scientific and Clinical Advisor
Waljit Dhillo is a Professor in Endocrinology & Metabolism, Consultant Endocrinologist and an NIHR Research Professor. He is Head of the Section Endocrinology and Investigative Medicine at Imperial College London. He completed his medical training at St Bartholomew’s Hospital Medical School, University of London which included an Intercalated BSc in Biochemistry (awarded First Class Honours). He completed a PhD as a Wellcome Trust Clinical Training Fellow at Imperial College with Professor Sir Steve Bloom. He has published 170 papers and has a h index of 48. He has recently been awarded a prestigious National Institute for Health Research (NIHR) Research Professorship.
Professor Dhillo’s translational research has investigated the KNDy hormones kisspeptin and neurokinin B as a potential novel therapies for reproductive disorders.
Professor Dhillo has carried out the ‘first into man’ studies of kisspeptin. He has shown that kisspeptin potently stimulates reproductive hormone release in human male and female volunteers and in women with infertility. His recent work suggests that kisspeptin could be used as a more physiological trigger for egg maturation in IVF treatment.
Professor Dhillo has also carried out the studies of neurokinin B (which binds to the NK3 receptor) in healthy volunteers and shown that it causes flushing. Following on from this he has carried out the first randomised controlled study to show that NK3 receptor antagonism can powerfully reduce hot flushes in menopausal women (Lancet 2017). Professor Dhillo is working with KaNDy therapeutics, independently, through Imperial Consultants.